South Africa's AIDS activists say new neviripine programme is not enough.
A
A
Baleta
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000191:economics*; D003365:Costs and Cost Analysis; D005260:Female; D005380:Financing, Government / Q000191:economics*; D006679:HIV Seropositivity / Q000188:drug therapy* / Q000191:economics; D015276:Health Care Rationing / Q000191:economics; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D019829:Nevirapine / Q000008:administration & dosage / Q000191:economics*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000191:economics; D013019:South Africa
D019380:Anti-HIV Agents; D019829:Nevirapine